PLENARY SESSION II: ADVANCES IN HIV PREVENTION: RECENT SUCCESSES AND FUTURE DIRECTIONS

There have been notable successes in HIV prevention over the past decade including the broad implementation of prevention for mother to child transmission, and the emergence of “treatment as prevention” from a number of perspectives including successful trials of pre-exposure prophylaxis and treatment of HIV+ partners in sero-discordant couples, as well as data from observational research. Mother-to-child transmission has declined greatly in much of the world including the US, but implementation and resource issues remain. In practice, treatment as prevention has varied in its effectiveness, depending on the setting and resources, and how these interact for different populations. This plenary will provide perspectives on HIV prevention research, implementation and policy. Mike Cohen, the Pi of the landmark HPTN052 trial which demonstrated how effective and consistent HIV treatment can protect uninfected partners, will talk about HPTN052 and new directions that build on its findings. Lynne Mofenson, who played a major role in efforts to reduce mother-to-child transmission of HIV will describe efforts past, present, and future to prevent HIV transmission from mothers to their offspring. Greg Mellett will talk address research, policy and practice. Greg’s work has included the policy and research arenas, including major significant research among the population most affected by HIV in the US, African American gay men.

Myron “Mike” Cohen, UNC-Chapel Hill, “HPTN 052. What Happened Next”

Lynn Mofenson, Elizabeth Glaser Pediatric AIDS Foundation, “Prevention of Mother-to-Child HIV Transmission – Past, Present, Future”

Greg Millett, American Foundation for AIDS Research, “Directions for HIV Prevention Policy & Research”